BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38335449)

  • 21. A prospective head-to-head comparison of
    Jiang Y; Liu Q; Wang G; Sui H; Wang R; Wang J; Zhu Z
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4218-4227. PubMed ID: 35657429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (68)Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitter.
    Fellner M; Biesalski B; Bausbacher N; Kubícek V; Hermann P; Rösch F; Thews O
    Nucl Med Biol; 2012 Oct; 39(7):993-9. PubMed ID: 22633217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and Evaluation of [
    Dam JH; Langkjær N; Baun C; Olsen BB; Nielsen AY; Thisgaard H
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain metastasis in carcinoma breast demonstrated on (68)Ga NOTA-bisphosphonate PET/CT.
    Passah A; Tripathi M; Kumar R; Das CJ; Goyal A; Bal CS
    Clin Nucl Med; 2014 Jul; 39(7):653-4. PubMed ID: 24686213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging.
    Ebenhan T; Zeevaart JR; Venter JD; Govender T; Kruger GH; Jarvis NV; Sathekge MM
    J Nucl Med; 2014 Feb; 55(2):308-14. PubMed ID: 24434293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of
    Zhou N; Liu C; Guo X; Xu Y; Gong J; Qi C; Zhang X; Yang M; Zhu H; Shen L; Yang Z
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):161-175. PubMed ID: 32564171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
    Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V
    J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Translation and First In-Human Use of [
    Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
    Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
    Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC
    J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting.
    Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM
    Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Al
    Gai Y; Yuan L; Sun L; Li H; Li M; Fang H; Altine B; Liu Q; Zhang Y; Zeng D; Lan X
    J Biol Inorg Chem; 2020 Feb; 25(1):99-108. PubMed ID: 31745667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Gallium-67/68-Labeled Antibody Fragment for Immuno-SPECT/PET Shows Low Renal Radioactivity Without Loss of Tumor Uptake.
    Uehara T; Yokoyama M; Suzuki H; Hanaoka H; Arano Y
    Clin Cancer Res; 2018 Jul; 24(14):3309-3316. PubMed ID: 29666303
    [No Abstract]   [Full Text] [Related]  

  • 33. Gallium-68 labeled Ubiquicidin derived octapeptide as a potential infection imaging agent.
    Bhatt J; Mukherjee A; Shinto A; Koramadai Karuppusamy K; Korde A; Kumar M; Sarma HD; Repaka K; Dash A
    Nucl Med Biol; 2018; 62-63():47-53. PubMed ID: 29883883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation, Characterization, and Radiolabeling of [
    Ashhar Z; Yusof NA; Ahmad Saad FF; Mohd Nor SM; Mohammad F; Bahrin Wan Kamal WH; Hassan MH; Ahmad Hassali H; Al-Lohedan HA
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32526838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and evaluation of a radiogallium complex-conjugated bisphosphonate as a bone scintigraphy agent.
    Ogawa K; Takai K; Kanbara H; Kiwada T; Kitamura Y; Shiba K; Odani A
    Nucl Med Biol; 2011 Jul; 38(5):631-6. PubMed ID: 21718937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ImmunoPET imaging of human CD8
    Zhao H; Wang C; Yang Y; Sun Y; Wei W; Wang C; Wan L; Zhu C; Li L; Huang G; Liu J
    J Nanobiotechnology; 2021 Feb; 19(1):42. PubMed ID: 33563286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting Vulnerable Atherosclerotic Plaques by
    Jiang L; Zhu H; Li Y; Wu X; Wang H; Cheng Z
    Mol Pharm; 2019 Mar; 16(3):1350-1357. PubMed ID: 30742442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
    Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC
    J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [
    Zhang P; Zhao Z; Zhang L; Wu W; Xu Y; Pan D; Wang F; Yang M
    Nucl Med Biol; 2019; 74-75():19-24. PubMed ID: 31450071
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.